AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

The Russo family from “Wizards of Waverly Place” returns to Disney Channel with a campaign that melds cross-generational marketing tactics.

As for Gronk, he’s currently appearing with Sam Elliott in ads for USAA, the insurance company. It’s a memorable pairing: the greatest goof in sports joins forces with the greatest mustache in ...

GSK has claimed a new approval for its respiratory syncytial virus (RSV) vaccine Arexvy, currently locked in a battle for market share with rival shots from Pfizer and Moderna, that could lend it ...

The arrangement will run for three years in the first instance and, according to GSK, also “supports potential future co-development and commercialisation of Arexvy […] for adults 60 years and ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

The company is developing ACU193, a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD). “Dr Schacterle is a highly regarded leader who ...

The newly approved vaccine, known as Arexvy, represents an advance in preventive health measures, addressing a significant adult demographic at risk from RSV complications. With this approval, Canada ...

Nonprofits – 30% discount off the open rate is extended to all 501 C3 nonprofits. Does not apply to premium positions. All rates quoted are plus tax.

And to review, we now have three RSV vaccines that are FDA approved for adults, two protein subunit RSV vaccines, one by Pfizer called ABRYSVO that does not contain an adjuvant, and one by GSK called ...

Results from the ARC-10 Phase III study of Arcus Biosciences (NYSE: RCUS) and Gilead Sciences’ (Nasdaq: GILD) domvanalimab and zimberelimab combination therapy indicate a significant reduction in ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...